Transparansi Harga Obat dan Promosi Produk Kesehatan dalam Praktik Bisnis Farmasi
Keywords:
pharmaceutical ethics, price transparency, drug promotion, physician industry relations, consumer protectionAbstract
The pharmaceutical industry faces persistent ethical challenges regarding drug price transparency and health product promotion. This study examines the regulatory framework governing pharmaceutical business ethics in Indonesia, focusing on compliance gaps between legal provisions and actual practices. A qualitative document analysis method was employed, reviewing regulations including Minister of Health Regulation No. 98/2015 on Maximum Retail Price disclosure and Government Regulat ion No. 28/2024 on health product advertising. The analysis identifies three major compliance gaps. First, healthcare facilities frequently sell drugs above regulated prices through hidden administrative fees. Second, promotional content on digital platforms bypasses pre approval requirements using influencer marketing tactics. Third, sponsorship of physician conferences remains a channel for undue influence despite anti gratification laws. Weak sanction mechanisms and inadequate interagency coordination enable continued violations. Patient reporting systems are inaccessible and provide no compensation for overcharged consumers. The findings suggest that regulatory existence alone is insufficient without political commitment to enforcement. Recommended improvements include artificial intelligence based advertising monitoring, mandatory disclosure of industry physician financial relationships, and severe administrative penalties for repeat violators. These measures would protect patient rights and restore public trust in pharmaceutical services.
References
Agustini, K., Hurriyati, R., Gaffar, V., Tiana, B., & Novianti, W. (2022). The effectiveness of electronic purchase on ordering national health insurance drugs at the West Bandung pharmacy of Indonesia. Journal of Eastern European and Central Asian Research, 9(5), 815–823. https://doi.org/10.15549/jeecar.v9i5.1062
Arifin, S., Irfan, M., Darmawan, D., Putra, A. R., & Al Hakim, Y. R. (2014). Segmentation, Targeting, Positioning untuk Strategi Pemasaran Efektif. Jurnal Ekonomi dan Bisnis, 4(2).
Astărăstoae, V., Rogozea, L., Leaşu, F., & Roșca, Ștefan. (2024). Drug Promotions Between Ethics, Regulations, and Financial Interests. American Journal of Therapeutics, 31(3), e268–e279. https://doi.org/10.1097/mjt.0000000000001754
Batool, S., Qureshi, S., & Malik, S. (2024). Unethical Behavior of Pharmaceutical Companies. 37–43. https://doi.org/10.2174/9789815223859124010009
Bennett, S., & Chan, T. (2003). Pharmaceutical Supply Chains in Southeast Asia: Structure and Inefficiencies. Health Policy and Planning, 18(4), 384-395.
Ceretta, J. C., Seibert, R. M., & Callegaro, A. R. C. (2023). Hospital management: Operational audit as a strategic tool for waste control. https://doi.org/10.56238/globalhealthprespesc-034
Charmaz, K. (2006). Constructing Grounded Theory: A Practical Guide through Qualitative Analysis. Sage Publications.
Darmawan, D. (2012). Studi Tentang Peran Persepsi Harga Premi dan Pengalaman Merek Terhadap Minat Mereferensikan Merek. Jurnal Ekonomi dan Bisnis, 2(2), 38–44.
Darmawan, D., Mardikaningsih, R., & Putra, A. R. (2013). Proses integrasi fungsi SDM dengan fungsi pemasaran, produksi, dan keuangan. Jurnal Ekonomi dan Bisnis, 3(1), 32–42.
Fared, M. A. & D. Darmawan. (2021). Use of Consumer Behaviour Data for Personalised Advertising in Digital Marketing, Studi Ilmu Sosial Indonesia, 1(2), 93-108.
Fink, A. (2005). Conducting Research Literature Reviews: From the Internet to Paper (2nd ed.). Sage Publications.
Glaser, B. G., & Strauss, A. L. (1967). The Discovery of Grounded Theory: Strategies for Qualitative Research. Aldine Publishing Company.
Gordon, J., Potthast, H., Stahl, M., & Rägo, L. (2017). World Health Organisation (WHO). 307–331. https://doi.org/10.1007/978-3-319-68078-1_11
Irawan, B., Januarita, R., & Suminar, S. R. (2023). Legal and Ethical Protection in Drug Distribution: Examining Health Efforts and Drug Supervision in Indonesia. Intellectual Law Review/Intellectual Law Review, Cianjur, 1(2), 53–65. https://doi.org/10.59108/ilre.v1i2.40
Khayru, R. K., Wisnujati, R. N. S., Darmawan, D., & Issalillah, F. (2021). Pengamatan Loyalitas Merek Obat Herbal Berdasarkan Kemasan dan Harga. Jurnal Simki Economic, 4(2), 121-132.
Kim, S. D., Nathanson, P., & Feudtner, C. (2023). Argument analysis of the ethical claims made by the pharmaceutical industry regarding drug pricing. Bioethics Open Research, 1, 2–2. https://doi.org/10.12688/bioethopenres.17473.1
Komesaroff, P. A., & Kerridge, I. H. (2002). Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry. The Medical Journal of Australia, 176. https://doi.org/10.5694/j.1326-5377.2002.tb04318.x
Mansyur, M., Mujito, M., Halizah, S. N., Gautama, E. C., & Khayru, R. K. (2024). The Negligence of Healthcare Workers in the Use of Herbal Medicines: Legal Implications and Impacts on Patients. International Journal of Service Science, Management, Engineering, and Technology, 6(2), 29-37.
Mardikaningsih, R, S. N. Halizah, R. Nuraini, & D. Darmawan. (2021). Clashes Between Local Values and Green Marketing Approaches in Traditional Communities, Studi Ilmu Sosial Indonesia, 1(2), 157-172.
Mardikaningsih, R., & Aisyah, N. (2025). Strategi Green Pricing pada Produk Mewah Berkelanjutan: Elastisitas Harga dan Komunikasi Nilai Premium. Jurnal Ekonomi dan Bisnis, 15(2).
Mardikaningsih, R., Hariani, M., & Issalillah, F. (2025). Green Marketing Otentik dan Greenwashing: Respons Konsumen Terhadap Klaim Lingkungan. Jurnal Ekonomi dan Bisnis, 15(1).
Mintzes, B. (2005). Direct to Consumer Advertising of Prescription Drugs in Canada. British Medical Journal, 330(7489), 482-484.
Mulyono, E., Saputra, R., & Khayru, R. K. (2024). Health Product Advertising Regulations and the Legal Consequences of Misleading Claims. Journal of Social Science Studies, 4(1), 349-358.
Nadjib, M., Sari, K. I. P., & Yunita. (2021). Capturing Pharmaceuticals Expenditures in Indonesia 2012. https://doi.org/10.13140/rg.2.2.33989.27366
Ortiz, E. (2022). Economic Considerations in The Provision and Use of Medicines1. 186–210. https://doi.org/10.4324/9781003282143-7
Peraturan Menteri Kesehatan Nomor 76 Tahun 2013 tentang Iklan Alat Kesehatan dan Perbekalan Kesehatan Rumah Tangga.
Peraturan Menteri Kesehatan Nomor 98 Tahun 2015 tentang Pemberian Informasi Harga Eceran Tertinggi Obat.
Peraturan Pemerintah Nomor 28 Tahun 2024 tentang Peraturan Pelaksanaan Undang Undang Kesehatan.
Rachim, R., Hardyansah, R., & Khayru, R. K. (2024). The Obligation of Medical Cost and Risk Information Transparency by Private Healthcare Providers in Indonesian Legal Construction. Journal of Social Science Studies, 4(2), 207-222.
Sari, I. P., & Darwati, D. (2023). Gratification in indonesian medical practice. 2(1), 31–38. https://doi.org/10.58631/injurity.v2i1.22
Satibi, S., P, L. K. K., P, M. A., Hutasoit, M. B., & Pribadi, P. (2022). Analysis of e-catalogue drug prices in the era of Universal Health Coverage in the Indonesian pharmaceutical industry. Фармация, 69(2), 555–562. https://doi.org/10.3897/pharmacia.69.e83068
Sinambela, E. A. & D. Darmawan. (2021). Relevance of Email Marketing in the Contemporary Digital Marketing Communication Mix, Studi Ilmu Sosial Indonesia, 1(2), 301-324.
Sinambela, E. A. (2021). Peran Earning Per Share (EPS) dan Deviden Per Share (DPS) Terhadap Harga Saham. Journal of Trends Economics and Accounting Research, 2(1), 6-10.
Sinambela, E. A., & Aprilianti, E. T. (2013). Value based pricing sebagai pendekatan optimal dalam penentuan harga. Jurnal Ekonomi dan Bisnis, 3(1), 43–54.
Sinambela, E. A., & Djaelani, M. (2021). Analisis Rancangan Perencanaan Biaya dengan Metode Perhitungan Biaya Nyata Pada Pelaksanaan Proyek Perumahan Sederhana. Journal of Trends Economics and Accounting Research, 2(2), 32-36.
Undang Undang Nomor 20 Tahun 2001 tentang Pemberantasan Tindak Pidana Korupsi.
Undang Undang Nomor 8 Tahun 1999 tentang Perlindungan Konsumen.
Velasquez, G., & Boulet, P. (2000). Globalization and Access to Drugs: Perspectives from the WHO. Journal of International Development, 12(3), 377-388.
Wazana, A. (2000). Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift? Journal of the American Medical Association, 283(3), 373-380.
Widnyana, I. M. A., & Winia, I. N. (2024). Policy on Prohibition of Advertising Traditional Health Services Conducted by Traditional Healers in Bali. International Journal of Social Studies., 2(2). https://doi.org/10.25078/ijoss.v2i2.4380
Wisnujati, N. S., Masithoh, N., & Mardikaningsih, R. (2014). Strategi Bauran Pemasaran dalam Praktik Usaha Mikro Kecil Menengah. Jurnal Ekonomi dan Bisnis, 4(1), 25–36.
Vitrianingsih, Y., Safira, M. E., Khayru, R. K., & Issalillah, F. (2023). Competition Law Implementation in the Herbal Industry to Prevent Adverse Practices for Businesses and Consumers. Journal of Social Science Studies, 3(1), 133-138.
